Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-218

@whytee

No argument, no one listens to or believes what SI says. I watched the SP tank (via his instos mates) after he told the market he thought MSB would have FDA approval by the end of the year. There was a time when that took the share price to over $10. Those days are not coming back unless there is FDA approval.

I think the FDA are thoroughly implicated. Don't forget, the trial met the primary. You're right though, until approval, there are absolutely no guarantees. I personally think it's now only a matter of a short period of time. I also think if the FDA approves the assays and/or approves GVHD in any way, the SP will be the hottest share on the planet.

I allowed myself to indulge there but, we will see.